MLEC (Moolec Science) Company Net Assets

The charts illustrating the price evolution of Moolec Science SA (MLEC) on the GURU.Markets platform demonstrate the dynamics of an asset valued at 0.00. The business relies on Argentine gene laboratories and external processing utilizing buffer storage. Growth is driven by patents for protein synthesis in legumes and FDA approval. Moolec Science SA (MLEC) is implementing molecular farming, replacing the traditional livestock sector with high-tech agronomy.

Moolec Science SA leverages molecular farming innovations to synthesize animal proteins in plants, radically reducing production costs and establishing a foundation for future free cash flow. The trend in equity levels based on book value reflects the remaining net assets after deducting all liabilities, where a declining line signals risks, while steady growth confirms the fundamental resilience of the business.